OOIR: Observatory of International Research

Papers

(The median citation count of International Clinical Psychopharmacology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Diabetes mellitus in patients with chronic bipolar disorder: prevalence, clinical correlates and relationship with homocysteine	36
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients	26
Innovation in psychopharmacology	23
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	17
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study	16
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	16
A comparative study of depressive and anxiety symptoms, insomnia, and sleepiness in patients with obstructive sleep apnea, restless legs syndrome, or both (CO-ROSA): preliminary findings from a retros	12
Aripiprazole: examining the clinical implications of D2 affinity	12
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	12
The role of personality traits in following quarantine orders during the COVID-19 pandemic	11
On the benefits of therapeutic drug monitoring for patients undergoing treatment with antipsychotic agents	10
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	10
Efficacy and safety of agomelatine versus SSRIs/SNRIs for post-stroke depression: a systematic review and meta-analysis of randomized controlled trials	10
Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study	10
Unhealthy lifestyle impacts on biological systems involved in stress response: hypothalamic–pituitary–adrenal axis, inflammation and autonomous nervous system	10
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	10
Suicidality and psychotic episodes after starting aripiprazole: two case reports	10
Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10	9
Investigating the psychological effects of home quarantine during the early peaks of the COVID-19 pandemic: a survey from Iran	9
Prevalence of obsessive-compulsive symptoms and their psychosocial correlates among medical students during COVID-19 pandemic	9
Neuroscience-based nomenclature as a teaching tool, introduction and pilot study	9
Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence	8
Neuropsychiatric symptoms in a patient under cystic fibrosis transmembrane conductance regulator modulators treatment: a case report	8
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study	8
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	8

Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology	8
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial	8
In search of clinical targets for suicide prevention in major depressive disorder	8
No gender differences in the pharmacological emergency treatment of schizophrenia: results of a 21-year observation	7
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	7
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	7
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system	7
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report	6
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	6
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments	6
Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report	6
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	6
DRESS syndrome: quetiapine associated case report and literature review	6
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	6
Treatment of high dose of intravenous midazolam abuse: a case report	6
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder	5
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	5
Pharmacologic treatment of depression in Alzheimer’s disease	5
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	5
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	5
Allergic reaction induced by subcutaneous administration of ketamine: a case report	5
Case report and systematic review of cerebellar vermis alterations in psychosis	5
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	5
Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial	5
Suicidality in a psychiatric inpatient unit: a 2-year retrospective study in Umbria, central Italy	5
Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports	5
Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression	5
Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019	4
Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding	4
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	4
Does slow release oral morphine have impact on craving and impulsivity in heroin dependent individuals?	4
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	4
A retrospective naturalistic study on the psychopharmacological treatment of schizoaffective disorder	4
Valbenazine for tardive dyskinesia: a systematic review and network meta-analysis	4
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder	4
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol	4
Antidepressant psychopharmacology: is inflammation a future target?	4
Psychometric validation of the Persian version of the Mental Health Knowledge Schedule	4
Does tramadol dependence impair cognitive functions?	4
The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study	4
Is Pilates effective in improving depressive disorders? A comprehensive overview	4
Clinical specificity profile for novel rapid acting antidepressant drugs	4
Fine-tuning of psychopharmacological treatments	3
Open issues in bipolar and antipsychotic treatments	3
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression	3
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors	3
Social withdrawal and neurocognitive correlates in schizophrenia	3
Brexpiprazole augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary retrospective observational study	3
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	3
Case series on aripiprazole and dopamine supersensitivity psychosis	3

Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review	3
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial	3
Frequency, risk factors, and impacts on quality of life of the restless legs syndrome and side effects among antidepressant users in a tertiary hospital: an observational cross-sectional study	3
Interplay of environmental and clinical factors in psychiatric disorders	3
l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial	3
Lurasidone as add-on to fluoxetine in obsessive-compulsive disorder with comorbid restrictive anorexia: a case report	3
Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland	3
The effect of early or late initiation of long-acting antipsychotics on the caregiver burden in schizophrenia	3
Parasomnia induced by lemborexant: a case report	3
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder	3
Risk of conversion to bipolar disorder in patients with late-onset major depression	3
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	3
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	2
Can bupropion treat COVID-19–induced brain fog? A case series	2
Focus on antipsychotics and related therapeutic drug monitoring	2
Vortioxetine improves cognition in mild cognitive impairment	2
Examining age of onset phenotype in the spectrum of mood disorders	2
Advances in the treatment of depression	2
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report	2
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	2
Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database	2
Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders	2
Managing depression in the elderly: real-world clinical considerations and perspectives	2
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	2
Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates	2
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study	2
Atypical antipsychotics in the treatment of psychotic symptoms in Alzheimer’s disease: a systematic review	2
Successful clozapine rechallenge after myopericarditis: a case report	2
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	2
A comparative study of the efficacy of venlafaxine and naltrexone for relapse prevention in patients with opioid use disorder attributed to tramadol	2
Ketamine for depression: a potential role in requests for Medical Aid in Dying?	2
Bipolar disorder and Susac syndrome: a case report	2
Differed spontaneous dissociative symptoms following the use of esketamine intranasal spray in a patient suffering from treatment-resistant depression: a case report	2
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry	2
Effects of acute pain medications on posttraumatic stress symptoms in early aftermath of trauma	2
Catatonic postpartum paternal depression as a first debut of a bipolar disorder: a case report	2
Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study	2
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder	2
Mirtazapine in schizophrenia – an undeservedly overlooked option?	2
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	2
Risk of corrected QT interval prolongation in patients receiving antipsychotics	2
It is ethical to publish successful case reports about patient with treatment-resistant depression	2
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial	2
Antidepressants use in Italy: an ecological study of national and regional trends and associated factors	2
Safety and efficacy of daridorexant in the treatment of insomnia: a systematic review and meta-analysis of randomized controlled trials	2
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts	2
Manic episode in a patient with pancreatic adenocarcinoma: a case report	2
Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea	2
Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia	2
Treatment options for depression in Parkinson’s disease: a mini-review	2
Microsampling for therapeutic drug monitoring in psychiatric practice	2
Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis	2